$6 million upfront with up to approximately $13.4 million of potential aggregate gross proceeds upon the exercise in full of warrantsTEL AVIV, Israel and RALEIGH, N.C., June 22, 2026 /PRNewswire/ — RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or…
News provided by PR Newswire.














